Kun-San Clifford Chao (K S Clifford Chao, K S Clifford Chao)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 25

Top Topics

Locally Advanced

Radiation Induced

Lymph Node Metastasis

Top Venues

Cell death & disease

Journal for immunotherapy of cancer

Cancer immunology, immunotherapy : CII

This page only lists publications with an associated author ORCID identifier.

Publications

Kevin Chih-Yang Huang, Shu-Fen Chiang, Pei-Chun Lin, Wei-Ze Hong, Pei-Chen Yang, Hui-Ping Chang, Shin-Lei Peng, Tsung-Wei Chen, Tao-Wei Ke, Ji-An Liang, William Tzu-Liang Chen, Kun-San Clifford Chao
TNFα modulates PANX1 activation to promote ATP release and enhance P2RX7-mediated antitumor immune responses after chemotherapy in colorectal cancer. Cell death & disease 15 (1) (2024)
Kevin Chih-Yang Huang, William Tzu-Liang Chen, Jia-Yi Chen, Chien-Yueh Lee, Chia-Hsin Wu, Chia-Ying Lai, Pei-Chen Yang, Ji-An Liang, An-Cheng Shiau, Kun-San Clifford Chao, Tao-Wei Ke
Neoantigen-augmented iPSC cancer vaccine combined with radiotherapy promotes antitumor immunity in poorly immunogenic cancers. NPJ vaccines 9 (1) (2024)
Kevin Chih-Yang Huang, Shu-Fen Chiang, Pei-Chun Lin, Wei-Ze Hong, Pei-Chen Yang, Hui-Ping Chang, Shin-Lei Peng, Tsung-Wei Chen, Tao-Wei Ke, Ji-An Liang, William Tzu-Liang Chen, Kun-San Clifford Chao
TNFα modulates PANX1 activation to promote ATP release and enhance P2RX7-mediated antitumor immune responses after chemotherapy in colorectal cancer. Cell death & disease 15 (1) (2024)
Kevin Chih-Yang Huang, Shu-Fen Chiang, Hsin-Yu Chang, Wei-Ze Hong, Jhen-Yu Chen, Pei-Chih Lee, Ji-An Liang, Tao-Wei Ke, Shin-Lei Peng, An-Cheng Shiau, Tsung-Wei Chen, Pei-Chen Yang, William Tzu-Liang Chen, Kun-San Clifford Chao
Colorectal cancer-specific IFNβ delivery overcomes dysfunctional dsRNA-mediated type I interferon signaling to increase the abscopal effect of radiotherapy. Journal for immunotherapy of cancer 12 (5) (2024)
Kevin Chih-Yang Huang, Shu-Fen Chiang, Hsin-Yu Chang, Wei-Ze Hong, Jhen-Yu Chen, Pei-Chih Lee, Ji-An Liang, Tao-Wei Ke, Shin-Lei Peng, An-Cheng Shiau, Tsung-Wei Chen, Pei-Chen Yang, William Tzu-Liang Chen, Kun-San Clifford Chao
Colorectal cancer-specific IFNβ delivery overcomes dysfunctional dsRNA-mediated type I interferon signaling to increase the abscopal effect of radiotherapy. Journal for immunotherapy of cancer 12 (5) (2024)
Kevin Chih-Yang Huang, William Tzu-Liang Chen, Jia-Yi Chen, Chien-Yueh Lee, Chia-Hsin Wu, Chia-Ying Lai, Pei-Chen Yang, Ji-An Liang, An-Cheng Shiau, Kun-San Clifford Chao, Tao-Wei Ke
Neoantigen-augmented iPSC cancer vaccine combined with radiotherapy promotes antitumor immunity in poorly immunogenic cancers. NPJ vaccines 9 (1) (2024)
Kevin Chih-Yang Huang, Shu-Fen Chiang, Pei-Chun Lin, Wei-Ze Hong, Pei-Chen Yang, Hui-Ping Chang, Shin-Lei Peng, Tsung-Wei Chen, Tao-Wei Ke, Ji-An Liang, William Tzu-Liang Chen, Kun-San Clifford Chao
TNFα modulates PANX1 activation to promote ATP release and enhance P2RX7-mediated antitumor immune responses after chemotherapy in colorectal cancer. Cell death & disease 15 (1) (2024)
Kevin Chih-Yang Huang, Shu-Fen Chiang, Pei-Chun Lin, Wei-Ze Hong, Pei-Chen Yang, Hui-Ping Chang, Shin-Lei Peng, Tsung-Wei Chen, Tao-Wei Ke, Ji-An Liang, William Tzu-Liang Chen, Kun-San Clifford Chao
TNFα modulates PANX1 activation to promote ATP release and enhance P2RX7-mediated antitumor immune responses after chemotherapy in colorectal cancer. Cell death & disease 15 (1) (2024)
Kevin Chih-Yang Huang, Shu-Fen Chiang, Hsin-Yu Chang, Wei-Ze Hong, Jhen-Yu Chen, Pei-Chih Lee, Ji-An Liang, Tao-Wei Ke, Shin-Lei Peng, An-Cheng Shiau, Tsung-Wei Chen, Pei-Chen Yang, William Tzu-Liang Chen, Kun-San Clifford Chao
Colorectal cancer-specific IFNβ delivery overcomes dysfunctional dsRNA-mediated type I interferon signaling to increase the abscopal effect of radiotherapy. Journal for immunotherapy of cancer 12 (5) (2024)
Kevin Chih-Yang Huang, Shu-Fen Chiang, Hsin-Yu Chang, Wei-Ze Hong, Jhen-Yu Chen, Pei-Chih Lee, Ji-An Liang, Tao-Wei Ke, Shin-Lei Peng, An-Cheng Shiau, Tsung-Wei Chen, Pei-Chen Yang, William Tzu-Liang Chen, Kun-San Clifford Chao
Colorectal cancer-specific IFNβ delivery overcomes dysfunctional dsRNA-mediated type I interferon signaling to increase the abscopal effect of radiotherapy. Journal for immunotherapy of cancer 12 (5) (2024)
Chia-Chin Li, Ying-Chun Lin, Ji-An Liang, Kun-San Clifford Chao, Te-Chun Hsia, Chun-Ru Chien
Health Economic Evaluation of Proton Therapy for Lung Cancer: A Systematic Review. International journal of environmental research and public health 20 (6) (2023)
Kevin Chih-Yang Huang, Tao-Wei Ke, Jia-Yi Chen, Wei-Ze Hong, Shu-Fen Chiang, Chia-Ying Lai, Tsung-Wei Chen, Pei-Chen Yang, Liang-Chi Chen, Ji-An Liang, William Tzu-Liang Chen, Kun-San Clifford Chao
Dysfunctional TLR1 reduces the therapeutic efficacy of chemotherapy by attenuating HMGB1-mediated antitumor immunity in locally advanced colorectal cancer. Scientific reports 13 (1) (2023)
Chia-Chin Li, Ying-Chun Lin, Ji-An Liang, Kun-San Clifford Chao, Te-Chun Hsia, Chun-Ru Chien
Health Economic Evaluation of Proton Therapy for Lung Cancer: A Systematic Review. International journal of environmental research and public health 20 (6) (2023)
Chia-Chin Li, Ying-Chun Lin, Ji-An Liang, Kun-San Clifford Chao, Te-Chun Hsia, Chun-Ru Chien
Health Economic Evaluation of Proton Therapy for Lung Cancer: A Systematic Review. International journal of environmental research and public health 20 (6) (2023)
Yun-Shan Lin, Shu-Fen Chiang, Chia-Yi Chen, Wei-Ze Hong, Tsung-Wei Chen, William Tzu-Liang Chen, Tao-Wei Ke, Pei-Chen Yang, Ji-An Liang, An-Cheng Shiau, Kun-San Clifford Chao, Kevin Chih-Yang Huang
Targeting CD73 increases therapeutic response to immunogenic chemotherapy by promoting dendritic cell maturation. Cancer immunology, immunotherapy : CII (2023)
Kevin Chih-Yang Huang, Shu-Fen Chiang, Hsin-Yu Chang, William Tzu-Liang Chen, Pei-Chen Yang, Tsung-Wei Chen, Ji-An Liang, An-Cheng Shiau, Tao-Wei Ke, Kun-San Clifford Chao
Engineered sTRAIL-armed MSCs overcome STING deficiency to enhance the therapeutic efficacy of radiotherapy for immune checkpoint blockade. Cell death & disease 13 (7) (2022)
Kevin Chih-Yang Huang, Chia-Ying Lai, Wei-Ze Hong, Hsin-Yu Chang, Pei-Chun Lin, Shu-Fen Chiang, Tao-Wei Ke, Ji-An Liang, An-Cheng Shiau, Pei-Chen Yang, William Tzu-Liang Chen, Kun-San Clifford Chao
A Novel Engineered AAV-based Neoantigen Vaccine in Combination with Radiotherapy Eradicates Tumors. Cancer immunology research (2022)
Kevin Chih-Yang Huang, Shu-Fen Chiang, Tao-Wei Ke, Tsung-Wei Chen, Ching-Han Hu, Pei-Chen Yang, Hsin-Yu Chang, Ji-An Liang, William Tzu-Liang Chen, Kun-San Clifford Chao
DNMT1 constrains IFNβ-mediated anti-tumor immunity and PD-L1 expression to reduce the efficacy of radiotherapy and immunotherapy. Oncoimmunology 10 (1) (2021)
Kevin Chih-Yang Huang, Shu-Fen Chiang, Pei-Chen Yang, Tao-Wei Ke, Tsung-Wei Chen, Chen-Yu Lin, Hsin-Yu Chang, William Tzu-Liang Chen, Kun-San Clifford Chao
ATAD3A stabilizes GRP78 to suppress ER stress for acquired chemoresistance in colorectal cancer. Journal of cellular physiology 236 (9) (2021)
Kevin Chih-Yang Huang, Shu-Fen Chiang, Tao-Wei Ke, Tsung-Wei Chen, Ching-Han Hu, Pei-Chen Yang, Hsin-Yu Chang, Ji-An Liang, William Tzu-Liang Chen, Kun-San Clifford Chao
DNMT1 constrains IFNβ-mediated anti-tumor immunity and PD-L1 expression to reduce the efficacy of radiotherapy and immunotherapy. Oncoimmunology 10 (1) (2021)
Shu-Fen Chiang, Kevin Chih-Yang Huang, William Tzu-Liang Chen, Tsung-Wei Chen, Tao-Wei Ke, Kun-San Clifford Chao
An independent predictor of poor prognosis in locally advanced rectal cancer: rs867228 in formyl peptide receptor 1 (FPR1). Oncoimmunology 10 (1) (2021)
Kevin Chih-Yang Huang, Shu-Fen Chiang, Pei-Chen Yang, Tao-Wei Ke, Tsung-Wei Chen, Ching-Han Hu, Yi-Wen Huang, Hsin-Yu Chang, William Tzu-Liang Chen, Kun-San Clifford Chao
Immunogenic Cell Death by the Novel Topoisomerase I Inhibitor TLC388 Enhances the Therapeutic Efficacy of Radiotherapy. Cancers 13 (6) (2021)
Shu-Fen Chiang, Kevin Chih-Yang Huang, William Tzu-Liang Chen, Tsung-Wei Chen, Tao-Wei Ke, Kun-San Clifford Chao
Polymorphism of formyl peptide receptor 1 (FPR1) reduces the therapeutic efficiency and antitumor immunity after neoadjuvant chemoradiotherapy (CCRT) treatment in locally advanced rectal cancer. Cancer immunology, immunotherapy : CII 70 (10) (2021)
Kevin Chih-Yang Huang, Shu-Fen Chiang, Tsung-Wei Chen, William Tzu-Liang Chen, Pei-Chen Yang, Tao-Wei Ke, Kun-San Clifford Chao
Prognostic relevance of programmed cell death 1 ligand 2 (PDCD1LG2/PD-L2) in patients with advanced stage colon carcinoma treated with chemotherapy. Scientific reports 10 (1) (2020)
Shu-Fen Chiang, Kevin Chih-Yang Huang, Tao-Wei Ke, Tsung-Wei Chen, Yu-Ching Lan, Ying-Shu You, William Tzu-Liang Chen, Kun-San Clifford Chao
Upregulation of tumor PD-L1 by neoadjuvant chemoradiotherapy (neoCRT) confers improved survival in patients with lymph node metastasis of locally advanced rectal cancers. Cancer immunology, immunotherapy : CII 68 (2) (2018)